BVS Bioventus Inc.companySEC Filings & Insider Trading Activity 2026
Latest Bioventus Inc. (BVS) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on March 5, 2026, a 10-Q quarterly report filed on May 6, 2026, an 8-K current report filed on August 5, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Bioventus Inc. (BVS) (SEC CIK 1665988), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Go deeper on Bioventus Inc.
Ask AI about BVS filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting BVS positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on BVS.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Bioventus Inc. (BVS) 8-K current reports disclosing material events.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Aug 5, 2026 | - | - | - |
8-K | Jun 4, 2026 | - | - | |
8-K | May 21, 2026 | - | - | |
8-K | May 6, 2026 | - | - | |
10-Q | May 6, 2026 | Mar 28, 2026 | - | |
8-K | Mar 5, 2026 | - | Analysis | - |
10-K | Mar 5, 2026 | Dec 31, 2025 | - | |
10-Q | Nov 4, 2025 | Sep 27, 2025 | - | |
10-Q | Aug 6, 2025 | Jun 28, 2025 | - | |
10-Q | May 6, 2025 | Mar 29, 2025 | - | |
10-K | Mar 11, 2025 | Dec 31, 2024 | - | |
10-Q | Nov 5, 2024 | Sep 28, 2024 | - | |
10-Q | Aug 6, 2024 | Jun 29, 2024 | - | |
10-Q | May 7, 2024 | Mar 30, 2024 | - | |
10-K | Mar 12, 2024 | Dec 31, 2023 | - | |
10-Q | Nov 7, 2023 | Sep 30, 2023 | - | |
10-Q | Aug 8, 2023 | Jul 1, 2023 | - | |
10-Q | May 16, 2023 | Apr 1, 2023 | - | |
10-K | Mar 31, 2023 | Dec 31, 2022 | - | |
SC 13G | Feb 14, 2023 | - | - | |
10-Q | Nov 21, 2022 | Oct 1, 2022 | - | |
10-Q | Aug 12, 2022 | Jul 2, 2022 | - | |
SC 13D | Jul 21, 2022 | - | - | |
10-Q | May 11, 2022 | Apr 2, 2022 | - | |
10-K | Mar 11, 2022 | Dec 31, 2021 | - |
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate BVS share value held by 13F filers tracked by SignalX, by quarter.
- Dimensional Fund Advisors+107.9K (+14%)
- Goldman Sachs Group+103.6K (+28%)
- State Street Corp+97.3K (+11%)
- FMR LLC (Fidelity)+29.5K (+8%)
- Bank of America Corp+24.7K (+40%)
- Renaissance Technologies LLC125.6K (-20%)
- AQR Capital Management106.7K (-24%)
- D.E. Shaw & Co47.6K (-13%)
- Morgan Stanley43.5K (-14%)
- Millennium Management42.8K (-72%)
- Prudential Financial+193.8K
- Fifth Third Bancorp+161.9K
- Franklin Resources+55.9K
- U.S. Bancorp+51
- Vanguard Group Inc−2.98M
- JPMorgan Chase & Co−110.1K
- Principal Financial Group−81.4K
- Invesco Ltd−33.6K
Source: 13F-HR filings on SEC EDGAR (aggregated from 162 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest BVS SEC filings in 2026?
Bioventus Inc. (BVS) has filed a 10-K annual report on March 5, 2026, a 10-Q quarterly report on May 6, 2026, an 8-K current report on August 5, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did BVS file its most recent 10-K annual report?
Bioventus Inc. (BVS) filed its most recent 10-K annual report on March 5, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view BVS 10-Q quarterly reports?
Bioventus Inc. (BVS)'s most recent 10-Q quarterly report was filed on May 6, 2026. SignalX displays every BVS 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has BVS filed recently?
Bioventus Inc. (BVS)'s most recent 8-K was filed on August 5, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find BVS insider trading activity (Form 4)?
SignalX aggregates every BVS Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does BVS file with the SEC?
Bioventus Inc. (BVS) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new BVS filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Bioventus Inc. (BVS).
What is BVS's SEC CIK number?
Bioventus Inc. (BVS)'s SEC CIK (Central Index Key) number is 1665988. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1665988 to look up all BVS filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Stay on top of Bioventus Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 34+ filings.